GLPwatch
Novo Nordisk replies to BMJ investigation on incretins and pancreatic damage.
BMJ · 2013
Last updated 2026-05-28| Journal | BMJ, 2013 |
|---|---|
| Citations | 1 |
| Relative citation ratio | 0.03 |
| NIH percentile | 4 |
| Molecules | — |
Full record and abstract on PubMed 23842435 ↗
BMJ · 2013
Last updated 2026-05-28| Journal | BMJ, 2013 |
|---|---|
| Citations | 1 |
| Relative citation ratio | 0.03 |
| NIH percentile | 4 |
| Molecules | — |
Full record and abstract on PubMed 23842435 ↗